Medifast maintains a strong, cash-heavy balance sheet and trades near liquidation value. Read more on MED stock and why it is a Hold.
Motley Fool Press Release.
BALTIMORE (AP) — BALTIMORE (AP) — Medifast Inc. (MED) on Monday reported a loss of $17.
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including Medifast (NYSE:MED) and its peers.
MED is shifting toward metabolic health with its 3.0 strategy, targeting broader growth, greater efficiency and a return to profitability.
Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Parsa Kiai, Director, on August 26, 2026, executed a purchase for 43,150 shares in Medifast (MED) fo
BALTIMORE, August 27, 2026--Medifast, Inc. (NYSE: MED) has announced the launch of the Medifast Metabolic Health Institute, established to advance metabolic health through rigorous research and credible, evidence-based education.
MED's Trilivy launch marks a major metabolic-health shift, backed by a 10-year roadmap and growing GLP-1 market focus.
Medifast (MED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
MED is reshaping its coach network around Executive Directors as productivity rises despite a sharp decline in active earning coaches.
This is the newest page. Registered accounts read further back.